BioStem Technologies® CEO to Appear on the Benzinga All Access Show on June 17,2022
17. Juni 2022 09:25 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA, June 17, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies® (OTC: BSEM), a leading, innovator focused on harnessing the natural properties of perinatal tissue in the development,...
BioStem Technologies Reports March 31, 2022 Record Quarterly Financial Results
16. Mai 2022 12:25 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., May 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies, Inc. Awarded Q Code for VENDAJE® Product Line From CMS.
23. Juli 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., July 23, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...